Scholars Central

Conference abstractPublished 30 Aug 2021

3D Equivariant Graph Neural Networks for Drug Discovery

Authors: Max Welling

Journal of Clinical Research and Pharmacy

Volume 4 · Issue 4 · Pages 1

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

In this talk I will first review a very useful machine learning tool for pharmaceutical applications: the Graph neural Network (GNN). A GNN analyses a signal on graph structured data, such as molecules or knowledge graphs. We then define the concept of equivariance, an organizing principle that embues the neural network with the right transformation properties under symmetry transformations. For instance, a molecule has the same properties whether we rotate it in space or not. We will finally apply the new 3D equivariant graph neural network to molecular data and show that it can successfully predict properties that are relevant for drug screening. If time permits we will briefly describe further relevant generalizations of this technnology.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Journal of Clinical Research and Pharmacy.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Clinical Research and Pharmacy
  • SubjectPharmaceutical Sciences
  • BylineArticles whose byline prints “Max Welling”